PE-backed healthcare services — behavioral health, value-based care, and oncology. Currently building at the frontier of healthcare AI.
McKinsey consultant turned thirty-year healthcare operator. P&L leadership across managed care, behavioral health, and oncology at Bravo Health, Collaborative Health Systems, and MIND 24-7. Currently Co-Founder & CSO of Covenant Specialty Health — AI-powered oncology care management. Past Board of Directors at MIND 24-7, Troy Medicare, and Primo Center for Women and Children.
Full P&L ownership across behavioral health, oncology, Medicare Advantage, and ACO program design. Thirty years building clinical programs that align payer incentives, manage medical cost, and scale — from early-stage to hundreds of millions in spend. ACO portfolio performance of $130M in earned savings on $2B in managed spend.
Built investor narratives, managed institutional PE diligence, and maintained board-level stakeholder relationships at growth-stage healthcare companies. Deep experience taking organizations from concept through multiple rounds of institutional capital and operating scale.
Hands-on practitioner of enterprise AI deployment — clinical frameworks, financial models, and operating systems. Can evaluate AI vendor claims, assess integration risk, and pressure-test AI ROI assumptions with the same rigor applied to any capital allocation decision.
Board of Directors at MIND 24-7, Troy Medicare (Chairman), and Primo Center for Women and Children. Advisory board positions at Latitude Health, Sciata, and Clarify Health. Governance experience spanning clinical operations, growth-stage accountability, PE-backed strategy, and nonprofit stewardship.
Thirty years in healthcare — McKinsey to managed care to founder. The through-line has always been the same: build the structure that makes scale possible, then execute.
My career has been defined by taking on complex, undermanaged problems in healthcare — behavioral health, oncology, managed care — and building the systems, teams, and financial models to solve them at scale.
What I bring to a board is the perspective of someone who has been in the room when the hard decisions were made: when to accelerate, when to conserve, how to hold clinical integrity alongside commercial pressure, and how to work with PE partners who understand the business as well as you do.
Today I am actively building Covenant Specialty Health at the frontier of healthcare AI — the strategic and technical questions I bring to a board are ones I am living in real time, not theorizing about.
I have built healthcare companies — not advised them from the outside. I know what the income statement looks like when you're scaling clinical headcount faster than revenue, and I know how to read the early warning signs that matter.
I deploy AI across clinical frameworks, financial modeling, and daily operations. I can evaluate AI vendor claims, assess integration risk, and pressure-test AI ROI assumptions with the same rigor I apply to any capital allocation question.
Active relationships with health plans, self-insured employers, and national broker networks. For PE-backed healthcare companies where payer contracting and employer market development are growth levers, this is a direct board contribution — not just advisory context.
I understand how PE sponsors think about value creation, exit timing, and management team accountability. I can be the board member who bridges operator instinct and investor discipline — useful in every boardroom, essential in high-growth healthcare.
PE-backed healthcare services companies in behavioral health, value-based care, oncology, and managed care — where thirty years of operator experience creates direct board value.
LinkedIn jeff@6040advisors.com